Table 1.

Clinical and demographic characteristics of our sample of patients with COVID-19 and seizures.

Age (mean, SD)	71.8 (17.1)
Women (n, %)	13/26 (50%)
Systemic comorbidities (n, %)	23/26 (88.4%)
Hypertension (n, %)	12/26 (46.1%)
Diabetes (n, %)	12/26 (46.1%)
Heart disease (n, %)	7/26 (26.9%)
Lung disease (n, %)	3/26 (11.5%)
History of epilepsy (n, %)	7/26 (26.9%)
Chronic antiepileptic treatment (n, %)	6/26 (23%)
Risk factors for epilepsy* (n, %) Dementia Brain tumour Cerebrovascular disease**	10/26 (38.4%) 5/10 (50%) 1/10 (10%) 5/10 (50%)
Severity of COVID-19*** (n, %) Mild disease Pneumonia ARDS	4/24 (16.6%) 19/24 (79.1%) 1/24 (4.1%)

*Patients with no history of epilepsy. Patients may present more than one risk factor.

**Chronic lesions of vascular origin detected before or during this study.

***Data unavailable for 2 patients.

ARDS: acute respiratory distress syndrome; SD: standard deviation.